Shield will acquire Echodyne, deal worth $5.3 billion, and raise $2.5 billion at a valuation of $28.8 billion.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.